130 related articles for article (PubMed ID: 3964537)
21. The potential of oncogene products as tumour markers.
Chan S; Sikora K
Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
[TBL] [Abstract][Full Text] [Related]
22. Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumour suppressor genes and can be monitored by the oncoprotein phenotype.
Pope B; Brown R; Luo XF; Gibson J; Joshua D
Leuk Lymphoma; 1997 May; 25(5-6):545-54. PubMed ID: 9250826
[TBL] [Abstract][Full Text] [Related]
23. In vitro transformation of mouse testis cells by oncogene transfection.
Morimoto H; Lee J; Tanaka T; Ishii K; Toyokuni S; Kanatsu-Shinohara M; Shinohara T
Biol Reprod; 2012 May; 86(5):148, 1-11. PubMed ID: 22357549
[TBL] [Abstract][Full Text] [Related]
24. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
[TBL] [Abstract][Full Text] [Related]
25. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
de Anta JM; Monzó M; Peris B; Ruano D
Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
27. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry.
Engelhard HH; Krupka JL; Bauer KD
Cytometry; 1991; 12(1):68-76. PubMed ID: 1900228
[TBL] [Abstract][Full Text] [Related]
29. Hormonal changes in urine and plasma in patients with various testicular tumours before and after treatment. II. Malignant teratoma of intermediate type B and malignant trophoblastic teratoma.
Lindenmeyer D; Hornung D; Körner F
Urol Int; 1973; 28(2):135-44. PubMed ID: 4703929
[No Abstract] [Full Text] [Related]
30. The prevalence and prognostic significance of trophoblastic proteins in testicular teratoma.
Masters JR; Parkinson MC; Miller ID; Horne CH
Diagn Histopathol; 1983; 6(3-4):247-52. PubMed ID: 6676077
[TBL] [Abstract][Full Text] [Related]
31. Identification of Two Additional Genomic Loci Responsible for experimentally induced testicular teratoma 2 and 3 (ett2 and ett3).
Miyazaki T; Fukui M; Inagaki E; Miki K; Takabayashi S; Katoh H; Ohira Y; Noguchi M; Tokumoto T
Zoolog Sci; 2018 Apr; 35(2):172-178. PubMed ID: 29623786
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
33. Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ.
Kang JL; Rajpert-De Meyts E; Skakkebaek NE
J Pathol; 1996 Feb; 178(2):161-5. PubMed ID: 8683382
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of p62c-myc in benign and malignant gastric epithelia.
Allum WH; Newbold KM; Macdonald F; Russell B; Stokes H
Br J Cancer; 1987 Dec; 56(6):785-6. PubMed ID: 3325095
[No Abstract] [Full Text] [Related]
35. [Nucleolar organizer regions enumeration in testicular teratoma].
Xu J; Li S; Yang D
Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):600-1. PubMed ID: 10678048
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.
Mándoky L; Géczi L; Bodrogi I; Tóth J; Csuka O; Kásler M; Bak M
Anticancer Res; 2004; 24(4):2219-24. PubMed ID: 15330164
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
Emanuel PO; Unger PD; Burstein DE
Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
[TBL] [Abstract][Full Text] [Related]
38. Dual parameter flow cytometry for deoxyribonucleic acid and intermediate filament proteins of residual mature teratoma. All tumor cells are aneuploid.
Looijenga LH; Oosterhuis JW; Ramaekers FC; de Jong B; Dam A; Beck JL; Sleijfer DT; Schraffordt Koops H
Lab Invest; 1991 Jan; 64(1):113-7. PubMed ID: 1990205
[TBL] [Abstract][Full Text] [Related]
39. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
Ando S; Matsuoka T; Kawai K; Sugita S; Joraku A; Kojima T; Suetomi T; Miyazaki J; Fujita J; Nishiyama H
Int J Urol; 2014 Oct; 21(10):992-8. PubMed ID: 24861729
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis.
Richie JP
J Urol; 2005 Nov; 174(5):1826-7. PubMed ID: 16217300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
